Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Raw Materials (2022 - 2026)

HeartSciences (HSCS) has disclosed Raw Materials for 4 consecutive years, with $322996.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Raw Materials changed 0.0% year-over-year to $322996.0, compared with a TTM value of $322996.0 through Oct 2025, changed 0.0%, and an annual FY2025 reading of $322996.0, changed 0.0% over the prior year.
  • Raw Materials was $322996.0 for Q4 2025 at HeartSciences, roughly flat from $322996.0 in the prior quarter.
  • Across five years, Raw Materials topped out at $359965.0 in Q2 2022 and bottomed at $322996.0 in Q2 2023.
  • Average Raw Materials over 4 years is $332854.4, with a median of $322996.0 recorded in 2023.
  • The sharpest move saw Raw Materials decreased 10.27% in 2023, then changed 0.0% in 2024.
  • Year by year, Raw Materials stood at $359965.0 in 2022, then fell by 10.27% to $322996.0 in 2023, then changed by 0.0% to $322996.0 in 2024, then changed by 0.0% to $322996.0 in 2025.
  • Business Quant data shows Raw Materials for HSCS at $322996.0 in Q4 2025, $322996.0 in Q3 2025, and $322996.0 in Q2 2025.